发明授权
US08163785B2 Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists
失效
吡唑并[5,1b]恶唑衍生物作为CRF-1受体拮抗剂
- 专利标题: Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists
- 专利标题(中): 吡唑并[5,1b]恶唑衍生物作为CRF-1受体拮抗剂
-
申请号: US13017243申请日: 2011-01-31
-
公开(公告)号: US08163785B2公开(公告)日: 2012-04-24
- 发明人: Nicholas James Devereux , Jeffrey McKenna
- 申请人: Nicholas James Devereux , Jeffrey McKenna
- 申请人地址: CH Basel
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: CH Basel
- 代理商 Michael G. Smith
- 主分类号: A61K31/424
- IPC分类号: A61K31/424 ; C07D498/14
摘要:
There are described 4-difluoromethoxyphenyl pyrazolo[5.1-b]oxazole derivatives of Formula I: which are useful as corticotropin releasing factor (CRF) receptor antagonists and as pharmaceuticals.
公开/授权文献
信息查询
IPC分类: